Please try another search
BG Medicine, Inc. (BG Medicine) is a commercial-stage diagnostics company. The Company is engaged in commercializing diagnostic products that may be used to help guide the care and management of patients suffering from heart failure and related disorders. The Company's BGM Galectin-3 Test is an in vitro diagnostic device that employs a manual micro-titer platform to measure galectin-3 levels in blood plasma or serum for use as an aid in assessing the prognosis of chronic heart failure in conjunction with clinical evaluation. The automated galectin-3 tests are being developed and commercialized by its diagnostic instrument manufacturing partners and will be performed on its partners' automated platforms. The Company's CardioSCORE test is a multi-analyte biomarker-based blood test that was designed as an aid in the assessment of near-term risk for atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Name | Age | Since | Title |
---|---|---|---|
Jeffrey M. Friedman | - | - | Co-Chairman of RDAB Board |
Stelios Papadopoulos | 74 | 2003 | Director |
Neil Kaplowitz | - | - | External Advisor of Ltbs Board |
Paul B. Watkins | - | - | Chairperson of LTBS Board |
Paul R. Sohmer | 73 | 2013 | CEO, President & Director |
Arnold J. Levine | 82 | - | Co-Chairman of RDAB Board |
John R. Senior | - | - | Member of LTBS Board |
Harry W. Wilcox | 69 | 2015 | Chairman |
James F. O'Connor | 81 | 2015 | Director |
Jeffrey R. Luber | 55 | 2016 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review